Emile E Voest Selected Research

Emile E Voest Research Topics

Disease

102	Neoplasms (Cancer) 03/2022 - 03/2002
15	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2004
8	Breast Neoplasms (Breast Cancer) 03/2022 - 07/2003
8	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 04/2007
6	Renal Cell Carcinoma (Grawitz Tumor) 04/2017 - 12/2004
6	Melanoma (Melanoma, Malignant) 01/2016 - 11/2002
5	Alzheimer Disease (Alzheimer's Disease) 03/2005 - 10/2002
4	Carcinoma (Carcinomatosis) 01/2022 - 05/2008
4	Hypoxia (Hypoxemia) 05/2009 - 01/2004
3	Disease Progression 11/2021 - 04/2017
3	Necrosis 10/2009 - 12/2002
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 01/2007
2	Body Weight (Weight, Body) 10/2017 - 12/2002
2	Esophageal Neoplasms (Esophageal Cancer) 11/2012 - 06/2009
2	Fatigue 09/2011 - 11/2005
2	Hypertension (High Blood Pressure) 12/2009 - 05/2008
2	Neuroblastoma 03/2005 - 03/2003
2	Amyloid Plaque 03/2005 - 03/2003
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Microsatellite Instability 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	COVID-19 01/2020
1	Respiratory Syncytial Virus Infections 01/2019
1	Pathologic Complete Response 01/2018
1	Cysts 01/2018

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 01/2022 - 04/2006
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2007
13	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2003
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2007
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2017 - 03/2004
7	Monoclonal AntibodiesIBA 10/2017 - 09/2004
6	Angiogenesis InhibitorsIBA 01/2018 - 09/2004
6	Bevacizumab (Avastin)FDA Link 05/2011 - 04/2007
5	Cisplatin (Platino)FDA LinkGeneric 06/2015 - 03/2002
4	Messenger RNA (mRNA)IBA 03/2022 - 08/2006
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2017 - 06/2009
4	Cetuximab (Erbitux)FDA Link 09/2017 - 02/2009
4	Amyloid (Amyloid Fibrils)IBA 10/2012 - 03/2003
4	Gemcitabine FDA Link 12/2011 - 08/2007
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2011 - 09/2008
4	AngiostatinsIBA 07/2004 - 04/2002
3	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 02/2009
3	Tyrosine Kinase InhibitorsIBA 12/2017 - 05/2008
3	Everolimus FDA Link 08/2017 - 06/2015
3	IntegrinsIBA 04/2016 - 04/2006
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2011 - 02/2009
3	EnzymesIBA 09/2011 - 12/2002
3	Capecitabine (Xeloda)FDA Link 10/2010 - 02/2009
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2010 - 08/2006
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2010 - 01/2005
3	vatalanib (PTK787)IBA 02/2010 - 04/2007
3	Amyloid beta-PeptidesIBA 03/2005 - 10/2002
3	Peptides (Polypeptides)IBA 03/2005 - 10/2002
3	EndostatinsIBA 09/2004 - 03/2003
2	AntigensIBA 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2019 - 04/2010
2	ParaffinIBA 10/2019 - 02/2012
2	Formaldehyde (Formol)FDA Link 10/2019 - 02/2012
2	Hematoxylin (Haematoxylon)IBA 01/2018 - 12/2002
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2018 - 12/2002
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2017 - 08/2007
2	lumretuzumabIBA 09/2017 - 02/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2015 - 10/2009
2	VemurafenibIBA 09/2015 - 05/2015
2	ChemokinesIBA 02/2014 - 09/2006
2	ProdrugsIBA 09/2011 - 11/2008
2	PlatinumIBA 09/2011 - 11/2010
2	Immunoglobulin G (IgG)IBA 03/2010 - 09/2004
2	Oxi 4503IBA 10/2009 - 10/2009
2	Blood Proteins (Serum Proteins)IBA 08/2009 - 02/2007
2	Hemoglobins (Hemoglobin)IBA 01/2007 - 11/2005
2	AcidsIBA 08/2006 - 06/2004
2	Fibronectins (Fibronectin)IBA 06/2005 - 01/2004
2	PlasminogenIBA 03/2005 - 01/2003
2	VitronectinIBA 09/2004 - 08/2004
2	Collagen Type XVIII (Type XVIII Collagen)IBA 06/2003 - 03/2003
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021
1	olaparibIBA 11/2021
1	ChromograninsIBA 01/2021
1	SynaptophysinIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	NivolumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	Estrogen ReceptorsIBA 10/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019

Therapy/Procedure

30	Therapeutics 03/2022 - 04/2002
21	Drug Therapy (Chemotherapy) 01/2021 - 07/2003
7	Immunotherapy 01/2022 - 01/2018
4	Precision Medicine 01/2021 - 02/2016
3	Radiofrequency Ablation 10/2010 - 05/2009
2	Hepatectomy 05/2010 - 12/2002
2	Adjuvant Chemotherapy 07/2004 - 07/2003
1	Castration 11/2019